Zhongda'an: Wu Junye, the controlling shareholder, plans to reduce his holdings by no more than 2%

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Midea Completes Controlling Acquisition of Italian Medical Imaging Firm Esaote

Midea Group (美的集团) completed its acquisition of a controlling stake in Italian medical imaging company Esaote S.p.A. (百胜医疗) on October 9, the companies said. Esaote will join Midea Healthcare while continuing to operate as an independent business headquartered in Genoa, with research and manufacturing facilities in Italy and the Netherlands.

Pony.ai and Uber Plan London Tests for Gen-7 Robotaxis

Pony.ai (小马智行) and Uber (优步) said on October 8 that they plan to begin testing Pony.ai’s seventh-generation (Gen-7) robotaxis on London streets in the coming weeks. The announcement extends their European partnership, but sets out a testing plan rather than a launch date for passenger service.

Manus Parent Butterfly Effect Raises More Than $500 Million After Meta Deal Unwind

Butterfly Effect, the China-founded company behind AI agent Manus, has completed a funding round of more than US$500 million, the company announced on October 8. Boyu Capital and IDG Capital led the round, with existing investors Tencent, HSG and ZhenFund also participating. The company did not disclose its valuation or how it plans to use the proceeds.

ANTA Sports Becomes PUMA’s Largest Shareholder in €1.51 Billion Deal

ANTA Sports Products Limited（安踏体育用品有限公司）completed its acquisition of a 29.06% stake in PUMA SE on October 7, paying €1.5055 billion in cash to Artémis SAS, the investment company of the Pinault family. The transaction makes ANTA PUMA’s largest shareholder and gives the Chinese sportswear group a significant stake in a major European brand, while leaving PUMA independently governed.